COVID-19 vaccination in Botswana

Last updated

COVID-19 vaccination in Botswana
DateMarch 8, 2021 (2021-03-08) – present
Time(GMT +2)
Location Botswana
Cause COVID-19 pandemic
Target COVID-19
Budget$10 Million
Organised byMinistry of Health and Wellness
Participants150,019 total doses administered (7 June 2021)
  • 150,019 people with at least 1 dose administered
  • 0 people fully vaccinated
Website Registration Portal

COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.[ citation needed ]

Contents

Mass vaccination started on 26 March 2021, initially with AstraZeneca's Covishield vaccine. [1] As of 7 June 2021, Botswana has administered 150,019 doses. [2] [3]

Background

Vaccines On Order

Vaccine nameQuantityDoses ArrivedApproval
Pfizer-BioNTech 101,790101,790Green check.svg Approved
CoronaVac TBA200,000Green check.svg Approved
Covaxin 166,60066,600Green check.svg Approved
Janssen 1,200,0000Green check.svg Approved
Moderna 500,0000Green check.svg Approved
Oxford-AstraZeneca [4] 38,40038,400Green check.svg Approved

History

Timeline

February 2021

In February, Botswana spent 10 million dollars on purchasing vaccines. [5]

March 2021

Start of vaccinations of those aged 55 and older (phase 1) on 26 March, initially with 30,000 doses of Covishield donated by India and 33,600 doses purchased through the COVAX facility. [6] [7] [8]

April 2021

In the first four weeks 47,160 persons received their first inoculation. [9] A week later, on 30 April, the number of vaccinated persons had increased to 49,882. [10] [11]

May 2021

49,959 persons had received their first inoculation by 3 May; 53,375 by 7 May; and 142,864 by 28 May. [12]

On 29 May Botswana received 38,400 doses of the Oxford-AstraZeneca vaccine through COVAX, facilitated by UNICEF Botswana. [13] [14]

June 2021

On 3 June Botswana received 19,890 doses of the Pfizer-BioNTech vaccine through COVAX. A supply agreement with Moderna was announced. [12] [15] [16]

On 24 June Botswana received 200,000 doses of the CoronaVac vaccine. [17] By the end of the month 91,482 persons had been fully vaccinated.

July 2021

Vaccination of 55-year-olds and older resumed on 5 July. Health ministry officials announced their intention to extend vaccination to those aged 30 to 54 (phase 2) at the end of July. [17]

On 16 July, the Ministry of Health and Wellness reported a shortfall of 15,000 doses of the Oxford-AstraZeneca vaccine, initially foreseen for delivery in early June. To remedy the shortfall and ensure that those already vaccinated once with Oxford-AstraZeneca received their second inoculation within 12 weeks of the first, the Ministry recommended using the Moderna or Pfizer-BioNTech vaccines for the second dose in case Oxford-AstraZeneca was unavailable. [18]

On 30 July, the Minister for Health and Wellness informed that out of more than two million vaccine doses on order, only 282,890 doses had been delivered so far. [19] By the end of the month 127,362 persons had been fully vaccinated.

August 2021

The US delivers Pfizer-BioNTech COVID-19 vaccines to Botswana as part of the COVAX program in 2021 The United States Delivers COVID-19 Vaccine Doses to Botswana (51391201321).jpg
The US delivers Pfizer–BioNTech COVID-19 vaccines to Botswana as part of the COVAX program in 2021

In August, the chief executive officer of former president Ian Khama's SKI Khama Foundation issued a statement to the effect that the foundation had secured two million doses of the Oxford-AstraZeneca vaccine and two million doses of the Pfizer-BioNTech vaccine, sourced through U.S. firm KKM Global Group. The foundation offered the government to purchase the four million doses but needed a decision within five business days. Pfizer and AstraZeneca denied supplying any doses to KKM Global Group. [20] [21]

On 8 August, Botswana received 38,400 doses of the Oxford-AstraZeneca vaccine, followed by 108,000 doses of the Janssen vaccine. [22] On 19 August, it received 81,900 doses of the Pfizer-BioNTech vaccine donated by the United States. [23]

By 23 August, Greater Gaborone had run out of Oxford-AstraZeneca, Janssen and CoronaVac doses and had to halt first inoculations until further notice, pending the arrival of more vaccine doses. Inoculations resumed a month later.

By the end of the month, 337,989 persons had received their first inoculation and 215,502 had received both doses.

September 2021

On 5 September, Botswana received 404,494 doses of the CoronaVac vaccine. [24]

On 18 September, Botswana received the first 101,760 of 401,280 Oxford-AstraZeneca doses donated by Germany. [25]

On 23 September, Botswana received 50,400 doses of the Janssen vaccine donated by South Africa.

By the end of the month 245,559 persons had been fully vaccinated.

October 2021

On 14 October, Botswana received a first batch of 49,200 doses under the supply agreement with Moderna reached in June 2021. One week later, it received 72,000 doses of the Janssen vaccine purchased through the African Vaccine Acquisition Trust, followed by 72,000 more doses of the same vaccine on 25 October and 57,600 doses on 30 October.

By the end of the month 383,320 persons had been fully vaccinated, corresponding to 40% of the target population.

November 2021

On 18 November, Botswana received 100,260 doses of the Pfizer-BioNTech vaccine through COVAX.

By the end of the month 519,544 persons had been fully vaccinated, corresponding to 93% of the target population.

December 2021

Botswana received 525,230 doses of the Pfizer-BioNTech vaccine on 2 December; 200,070 doses of the same vaccine on 6 December; 151,200 and 79,200 of the Janssen vaccine on 6 and 8 December respectively. On 12 December it received 72,000 doses of the Janssen vaccine and 72,000 Oxford-AstraZeneca doses, followed by 737,100 doses of the Pfizer-BioNTech vaccine on 16 December.

By the end of the month 1.03 million persons had been fully vaccinated, exceeding the targeted population.

Progress

Cumulative vaccinations

Related Research Articles

COVAX Initiative to provide COVID-19 vaccines

COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO). It is one of the three pillars of the Access to COVID-19 Tools Accelerator, an initiative begun in April 2020 by the WHO, the European Commission, and the government of France as a response to the COVID-19 pandemic. COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines. UNICEF is the key delivery partner, leveraging its experience as the largest single vaccine buyer in the world and working on the procurement of COVID-19 vaccine doses, as well logistics, country readiness and in-country delivery.

The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Italy Immunization plan against COVID-19 in Italy

The COVID-19 vaccination campaign in Italy is a mass immunization campaign that was put in place by the Italian government in order to respond to the ongoing COVID-19 pandemic. It started on 27 December 2020, together with most countries in the European Union.

COVID-19 vaccination in Australia Ongoing COVID-19 vaccine program in Australia

The general COVID-19 vaccination in Australia program began on 22 February 2021 in response to the COVID-19 pandemic, and will continue with the goal of vaccinating all willing Australians before 2022. Front-line workers and aged care staff and residents will be the first Australians to be inoculated, before a gradual phased release to less-vulnerable and lower-risk population groups throughout 2021. The Therapeutic Goods Administration (TGA) approved four vaccines for Australian use in 2021: the Pfizer–BioNTech vaccine on 25 January, the Oxford–AstraZeneca vaccine on 16 February, Janssen vaccine on 25 June and the Moderna vaccine on 9 August. Although approved for use, the Janssen vaccine is not included in the Australian vaccination program.

COVID-19 vaccination in Romania started on 27 December 2020. It was announced that the process would be divided into three phases. Medical personnel would be vaccinated first, followed by the population at risk, and finally by the rest of the population. Vaccination was declared free and non-mandatory. As of May 2021, four types of vaccines were authorized to be used in Romania. This is the largest vaccination campaign in the modern history of Romania.

COVID-19 vaccination in Canada COVID-19 vaccination programme in Canada

COVID-19 vaccination in Canada is an ongoing, intergovernmental effort coordinated between the bodies responsible in the Government of Canada to acquire and distribute vaccines to individual provincial and territorial governments who in turn administer authorized COVID-19 vaccines during the COVID-19 pandemic in Canada. Provinces have worked with local municipal governments, hospital systems, family doctors and independently owned pharmacies to aid in part, or in full with vaccination rollout. The vaccination effort in full is the largest such immunization effort in the nation's history. The vaccination effort began December 14, 2020 and is currently ongoing.

COVID-19 vaccination in South Africa Plan to immunize against COVID-19 in South Africa

COVID-19 vaccination in South Africa is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Angola is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. As of 15 June 2021, Angola has administered 1,314,375 doses of vaccines.822,109 people with the first dose and 492,266 people fully vaccinated. Angola began their vaccination program shortly after receiving their first shipment of Oxford AstraZeneca vaccine in early March 2021.

Cape Verde has begun vaccinations against COVID-19.

The COVID-19 vaccination program in Colombia is an ongoing effort of mass immunization put in place by the Colombian government in order to respond to the ongoing COVID-19 pandemic. The COVID-19 virus was confirmed to have reached Colombia on 6 March 2020. Colombia's preparation and readiness for a vaccine program allowed it to join the first group of countries who received vaccines through COVAX. The first vaccine in Colombia was given to a nurse on 17 February 2021.

COVID-19 vaccination in Africa Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs have begun in many countries and territories in Africa. In June 2021, the World Health Organization predicted that 47 of Africa's 54 nations would fall short of the aim of vaccinating 10% of their people by September 2021. In June, Africa accounted for fewer than 1% of worldwide vaccine doses delivered.

COVID-19 vaccination in Vietnam Plan to immunize against COVID-19 in Vietnam

The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022. The Sputnik V was later approved for use on 23 March 2021. The Sinopharm BIBP vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were approved on 12 June 2021, 29 June 2021, and 15 July 2021, respectively. Vietnam approved Abdala vaccine from Center for Genetic Engineering and Biotechnology on 18 September 2021, and Covaxin from Bharat Biotech on 10 November 2021.

COVID-19 vaccination in Indonesia

The COVID-19 vaccination in Indonesia is an ongoing mass immunization in response to the COVID-19 pandemic in Indonesia. On 13 January 2021, the program commenced when President Joko Widodo was vaccinated at the presidential palace. In terms of total doses given, Indonesia ranks fifth in the world and second in Asia.

COVID-19 vaccination in Bangladesh Immunisation programme against COVID-19 in Bangladesh

Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.

COVID-19 vaccination in Japan

COVID-19 vaccination in Japan started later than in most other major economies. The country has frequently been regarded as "slow" in its vaccination efforts.

COVID-19 vaccination in Nepal Immunisation programme against COVID-19 in Nepal

Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal brought 2 million doses from Serum Institute of India (SII) and was one of the first to receive COVID-19 vaccines. The delivery of the first 1 million doses arrived on 21 February. In March, India's decision to ban exports of vaccines created uncertainty over whether Nepal would be able to continue its vaccinations. By April, SII had only provided half of the 2 million doses for which Nepal had paid in full. A spokesperson for the Indian Ministry of External Affairs rejected the notion of an export ban and said “We will export vaccines taking into account the domestic demand.” By late July, there was still uncertainty in Nepal over when SII would deliver the vaccines that were purchased, although Prime Minister Narendra Modi said India would "resume the supply of vaccines soon."

COVID-19 vaccination in Sri Lanka Plan to immunize against COVID-19

COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna vaccine through COVAX.

COVID-19 vaccination in Taiwan Plan to immunize against COVID-19

COVID-19 vaccination in Taiwan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 18 March 2021, vaccinations commenced on 22 March 2021, and will continue throughout the year with the goal of vaccinating 70% of the population by late October 2021.

COVID-19 vaccination in Egypt is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

References

  1. Foundation, Thomson Reuters. "Botswana to use AstraZeneca COVID-19 vaccine, minister says". news.trust.org. Retrieved 8 March 2021.
  2. "Botswana: COVID-19 daily vaccine doses 2021". Statista. Retrieved 16 June 2021.
  3. "COVAX roll-out - Botswana". www.gavi.org. Retrieved 16 June 2021.
  4. Reuters Staff (15 February 2021). "Botswana to use AstraZeneca COVID-19 vaccine, health minister says". Reuters. Retrieved 8 March 2021.
  5. "Botswana to start COVID-19 vaccination in March - Xinhua | English.news.cn". www.xinhuanet.com. Retrieved 8 March 2021.
  6. Mguni, Mbongeni; Basimanebotlhe, Tsaone (26 March 2021). "Vaccination starts today – Health PS". Mmegi. Retrieved 28 March 2021.
  7. MGUNI, MBONGENI (21 May 2021). "Mmegi Online :: Botswana dodges bullet as India suspends vaccine exports". Mmegi Online. Retrieved 16 June 2021.
  8. "UPDATE 1-Botswana to use AstraZeneca COVID-19 vaccine, minister says". finance.yahoo.com. Retrieved 16 June 2021.
  9. "Over 47 000 vaccinated". Daily News. 26 April 2021. Retrieved 26 April 2021.
  10. MGUNI, MBONGENI (11 June 2021). "Mmegi Online :: Govt taps private sector for P590m vaccine shortfall". Mmegi Online. Retrieved 16 June 2021.
  11. "UNHCR COVID-19 Response: Southern Africa, 1 - 30 April 2021 - Democratic Republic of the Congo". ReliefWeb. Retrieved 16 June 2021.
  12. 1 2 Mguni, Mbongeni (3 June 2021). "Moderna confirms supply deal with Botswana". Mmegi. Retrieved 3 June 2021.
  13. Nimi Princewill. "African countries have struggled to secure enough Covid-19 vaccines. So why are thousands of doses going to waste?". CNN. Retrieved 16 June 2021.
  14. "Moderna Submits Authorization Application for its COVID-19 Vaccine in Adolescents in Switzerland". www.businesswire.com. 14 June 2021. Retrieved 16 June 2021.
  15. "Botswana President receives first injection of Pfizer COVID-19 vaccine". in.news.yahoo.com. Retrieved 16 June 2021.
  16. "Moderna enters supply deal with Botswana for COVID-19 vaccine". news.yahoo.com. Retrieved 16 June 2021.
  17. 1 2 Kgamanyane, Nnasaretha (2 July 2021). "Phase Two COVID-19 vaccine to commence". Mmegi. Retrieved 8 July 2021.
  18. Phakedi, Tebogo (17 July 2021). "Botswana to use other vaccines for second shots due to delay in delivery of AstraZeneca". SABC. Retrieved 17 July 2021.
  19. Mguni, Mbongeni; Basimanebotlhe, Tsaone (3 August 2021). "Frustrations grow as only 14% purchased vaccines arrive". Mmegi. Retrieved 8 August 2021.
  20. Chakamba, Rumbi (12 August 2021). "Is Botswana's private COVID-19 vaccine offer too good to be true?". Devex. Retrieved 22 August 2021.
  21. Pheage, Tefo (11 August 2021). "Pfizer denies vaccine middlemen". The Botswana Gazette. Retrieved 22 August 2021.
  22. "The United States donates 81,900 doses of Pfizer vaccine to Botswana". U.S. Embassy in Botswana. 20 August 2021. Retrieved 21 August 2021.
  23. Dube, Mqondisi (14 August 2021). "Botswana tightens COVID-19 restrictions amid rising death toll". VOA. Retrieved 22 August 2021.
  24. "Le Botswana reçoit plus de 404 000 vaccins Sinovac COVID-19". News FR-24 (in French). 5 September 2021. Retrieved 6 September 2021.
  25. "First delivery of German-donated COVID vaccines to COVAX land in Mauritania, with other deliveries to follow". Gavi. 8 September 2021. Retrieved 18 September 2021.